HLS · HLS Therapeutics Inc. · Financials
Market Cap
136.42M CAD
Shares
30.94M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
$55.5M
-2%
FY2025
Net Income
-$12.43M
+36.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 |
|---|---|---|
| $55.5M | $56.62M | |
| -$12.88M | -$15.58M | |
| -$445K | $4.07M | |
| -$12.43M | -$19.66M | |
| -22.4% | -34.71% |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.